Roche Holding AG is nearing a deal to buy Philadelphia biotech company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.
from WSJ.com: US Business https://ift.tt/2ItKKLg
via IFTTT
No comments:
Post a Comment